Ocular Therapeutix Inc (OCUL) — Cash Flow-to-Debt Ratio
Ocular Therapeutix Inc (OCUL) has a Cash Flow-to-Debt Ratio of -0.44x as of March 2026, meaning its operating cash flow of $-65.99 Million could theoretically repay 0% of its total liabilities ($150.96 Million) in one year. Check earnings quality score of Ocular Therapeutix Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ocular Therapeutix Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Ocular Therapeutix Inc across 14 annual periods. Also explore balance sheet size of Ocular Therapeutix Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Ocular Therapeutix Inc (2012–2025)
Year-by-year debt coverage analysis for Ocular Therapeutix Inc. For market capitalisation and broader financial context, see OCUL company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.33x | $-204.88 Million | $153.75 Million | ▼ -41.1% |
| 2024 | -0.94x | $-134.68 Million | $142.59 Million | ▼ -116.4% |
| 2023 | -0.44x | $-70.23 Million | $160.93 Million | ▲ +16.6% |
| 2022 | -0.52x | $-59.60 Million | $113.91 Million | ▲ +6.7% |
| 2021 | -0.56x | $-65.55 Million | $116.89 Million | ▼ -94.5% |
| 2020 | -0.29x | $-53.55 Million | $185.77 Million | ▲ +69.4% |
| 2019 | -0.94x | $-77.58 Million | $82.37 Million | ▲ +28.9% |
| 2018 | -1.32x | $-49.23 Million | $37.17 Million | ▲ +23.2% |
| 2017 | -1.72x | $-50.47 Million | $29.28 Million | ▼ -16.2% |
| 2016 | -1.48x | $-34.00 Million | $22.93 Million | ▲ +9.0% |
| 2015 | -1.63x | $-33.74 Million | $20.72 Million | ▼ -54.9% |
| 2014 | -1.05x | $-20.50 Million | $19.50 Million | ▼ -553.6% |
| 2013 | -0.16x | $-12.64 Million | $78.62 Million | ▲ +8.1% |
| 2012 | -0.18x | $-12.59 Million | $71.90 Million | — |